Biopharma Daily Stock Updates - 01/06/21

$XBI $143.32 (+2.04%) 📈

PIPELINE:

$IMRA (-37.97%) - Imara Reports Phase 2a Clinical Trial Results of IMR-687 in Adult Patients with Sickle Cell Disease

https://imaratx.gcs-web.com/news-releases/news-release-details/imara-reports-phase-2a-clinical-trial-results-imr-687-adult

$RDHL (-3.76%) - RedHill Biopharma's RHB-204 Granted FDA Fast Track Designation for NTM Disease

https://ir.redhillbio.com/news-releases/news-release-details/redhill-biopharmas-rhb-204-granted-fda-fast-track-designation

$RDUS (+15.76%) - Radius Health, Inc. Announces Acquisition of Orphan Disease Program

https://ir.radiuspharm.com/news-releases/news-release-details/radius-health-inc-announces-acquisition-orphan-disease-program

$SELB (+8.22%) - Selecta Biosciences Announces Data in Non-Human Primates, FurtherValidating Multiple Potential Benefits of the ImmTORTM Platform in Gene Therapy

http://ir.selectabio.com/news-releases/news-release-details/selecta-biosciences-announces-data-non-human-primates-further

$ZNTL (-6.54%) - Zentalis Pharmaceuticals Announces the Initiation of Multiple Early-Stage Clinical Trials

https://ir.zentalis.com/news-releases/news-release-details/zentalis-pharmaceuticals-announces-initiation-multiple-early

FINANCE:

$RGNX (+8.39%) - Offering

http://ir.regenxbio.com/news-releases/news-release-details/regenxbio-announces-proposed-public-offering-common-stock-1